基本信息
浏览量:317
职业迁徙
个人简介
Eric L. Chang, MD, FASTRO uses advanced radiation therapy techniques to treat a variety of benign and malignant brain tumors, and spine tumors. He is considered a world authority in the use of radiation therapy in the treatment of benign conditions and malignant tumors of the central nervous system, and is highly experienced in handling both routine cases and the most complex cases requiring radiotherapeutic evaluation in a multi-disciplinary setting of experts comprising neuro-radiation oncologists, neurosurgeons and neuro-oncologists, and neuro-radiologists.
He has held research leadership roles including having served as member, and Chair of the M. D. Anderson Cancer Center Clinical Research Committee (CRC) Chair. He is the 2011 CNS track leader for the American Society for Clinical Oncology (ASCO) Scientific Program Committee, and member of the ASCO Cancer Education Committee. Dr. Chang is currently the co-leader for the American Society of Radiation Oncology (ASTRO) brain metastasis guidelines development task force and member of the Annual Program Committee of the Educational Council of ASTRO. He is a current member of the American College of Radiology Appropriateness Criteria Expert Panel on bone metastases. He has been listed in the Best Doctors Directory. Dr. Chang led a phase III randomized controlled trial on brain metastasis published in the Lancet Oncology 2009 which is starting to change the practice patterns for metastatic brain disease. Dr. Chang has been selected as a plenary speaker for past meetings of ASTRO and the American Association for Neurological Surgeons (AANS). He has authored or co-authored over 100 peer-reviewed papers and abstracts.
He has held research leadership roles including having served as member, and Chair of the M. D. Anderson Cancer Center Clinical Research Committee (CRC) Chair. He is the 2011 CNS track leader for the American Society for Clinical Oncology (ASCO) Scientific Program Committee, and member of the ASCO Cancer Education Committee. Dr. Chang is currently the co-leader for the American Society of Radiation Oncology (ASTRO) brain metastasis guidelines development task force and member of the Annual Program Committee of the Educational Council of ASTRO. He is a current member of the American College of Radiology Appropriateness Criteria Expert Panel on bone metastases. He has been listed in the Best Doctors Directory. Dr. Chang led a phase III randomized controlled trial on brain metastasis published in the Lancet Oncology 2009 which is starting to change the practice patterns for metastatic brain disease. Dr. Chang has been selected as a plenary speaker for past meetings of ASTRO and the American Association for Neurological Surgeons (AANS). He has authored or co-authored over 100 peer-reviewed papers and abstracts.
研究兴趣
论文共 471 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Seema Nagpal,Michael T Milano,Veronica L Chiang,Scott G Soltys,Alexandria Brackett,Lia M Halasz, Amit K Garg,Arjun Sahgal,Manmeet S Ahluwalia, Martin C Tom,Joshua D Palmer, Jonathan P S Knisley,
Neuro-oncology (2024)
Emily J Martin,Andrew R Bruggeman,Eric Chang,Sara Alcorn,Yolanda D Tseng,Malcolm D Mattes,Jared R Robbins, Candice Johnstone, Charles B Simone
Annals of palliative medicineno. 2 (2024): 465-467
Kaley Woods,Zhilei Liu Shen,Zhengzheng Xu,Hualin Zhang, Yutaka Natsuaki,Karen Cheng, Vivian Li, Nathan Kim,Lijun Ma,Eric Chang
CHINESE CLINICAL ONCOLOGYno. 5 (2023): 56-56
Stephanie K. Cheok,Cheng Yu, Jeffrey J. Feng,Robert G. Briggs,Frances Chow,Lindsay Hwang,Jason C. Ye,Frank J. Attenello, David Tran,Eric Chang,Gabriel Zada
NEUROSURGICAL FOCUSno. 2 (2023): E9-E9
Journal of neurosurgerypp.1-10, (2023)
Neuro-oncologyno. Supplement_5 (2023): v72-v73
引用0浏览0引用
0
0
Mark S. Shiroishi,Mark S. Shiroishi,Mark S. Shiroishi,Dane Weinert,Steven Y. Cen,Bino Varghese,Timothy Dondlinger,Melissa Prah,Jesse Mendoza, Sina Nazemi,Nima Ameli, Negin Amini,
Frontiers in Oncology (2023): 1156843-1156843
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn